U.S. Life Sciences Stock News

The Morning Bull - US Market Morning Update Friday, Jul, 24 2026 US stock futures are pointing lower this morning, with key contracts on the S&P 500 and Nasdaq down roughly 0.4% as investors focus on rising borrowing costs and stubborn oil driven price pressures. The US 10 year Treasury yield is around 4.65%, which means everything from mortgages to corporate loans is staying expensive. At the same time, US crude inventories climbed by 2.0 million barrels, part of a broader oil story that is...

In recent sessions, ConocoPhillips drew heightened investor attention as the stock outperformed major indices ahead of its August 6, 2026 earnings report, which occurred earlier this month. Despite expectations for meaningful earnings growth at that time, the stock held a Zacks Rank of #4 (Sell), underscoring a cautious stance from at least one analyst framework. We’ll now consider how this anticipation around the August earnings release, against a cautious analyst rating backdrop, might...

Weis Markets (WMK) shares are in focus after the company’s board declared a quarterly dividend of $0.34 per share, payable on August 10, 2026, to shareholders of record on July 27. See our latest analysis for Weis Markets. At a share price of $74.74, Weis Markets has cooled off in the short term, with the 1 day, 7 day and 30 day share price returns all down. However, the 90 day share price return of 8.76% and 5 year total shareholder return of 51.73% indicate that longer term momentum has...

In July 2026, General Motors reported second-quarter revenue of US$48,026 million and net income of US$1,305 million, raised its full-year earnings guidance, completed a US$14.47 billion share repurchase program covering 24.61% of its stock, affirmed a US$0.18 quarterly dividend, and filed a US$2.05 billion ESOP-related shelf registration. Beyond vehicle sales, GM highlighted accelerating growth in its software and subscription business, underscoring a shift toward higher-margin, recurring...

Nasdaq (NDAQ) reported second quarter 2026 earnings, giving investors fresh detail on how its exchange and technology businesses are performing. The update included revenue, profits, earnings per share, and year-to-date figures. See our latest analysis for Nasdaq. Nasdaq shares closed at $90.42, with the stock down over the year to date but recording a 9.61% 1 month share price return. The 3 year total shareholder return of 87.45% reflects stronger long term momentum. If Nasdaq's latest...

ON Semiconductor stock has delivered a 133.4% return over the past five years, yet its current valuation checks suggest the shares may be trading at a premium to an estimate of intrinsic value based on a Discounted Cash Flow (DCF) model and earnings multiples that both lean overvalued. A 133.4% return over five years highlights that ON Semiconductor has already rewarded long term holders, which can lower the margin of safety for new investors if expectations are high. Expectations for ON...

Why Cleveland-Cliffs Stock Is Back in Focus After Q2 Results Cleveland-Cliffs (CLF) has drawn fresh attention after reporting second quarter and half year 2026 results, showing higher sales and a much smaller net loss compared with the same periods last year. See our latest analysis for Cleveland-Cliffs. The latest earnings update appears to have shifted sentiment, with Cleveland-Cliffs' share price jumping 15.98% on the day and 15.01% over the past week. However, the year to date share price...

Eli Lilly stock has returned roughly 4x over the past five years, yet the current valuation picture is split, with the intrinsic value estimate pointing to meaningful upside while the broader checks suggest the shares are not an obvious bargain. Eli Lilly has delivered a very large 5 year return of about 406.7%, which puts extra scrutiny on whether recent gains already reflect the key growth drivers. Expectations around new therapies in obesity, neuroscience and oncology can support...

Intel’s latest earnings put a spotlight on how quickly money is moving toward AI hardware and the factories that support it. With Q2 revenue up 25% year on year, data centre and AI sales at $6.3b, and 2024 capital spending guidance lifted to $20b, investors are reconsidering which U.S. industrial and semiconductor related stocks might benefit or face tougher competition. This article looks at 3 stocks from a U.S. Industrial Reshoring and Semiconductor Manufacturing screener that appear...

Tractor Supply (NasdaqGS:TSCO) reported Q2 results that fell short of expectations and reduced its full year outlook. The company plans to close about 75 underperforming Petsense stores as part of a broader review of its pet specialty footprint. Management also outlined a slower pace of new store openings, citing ongoing adverse weather, weaker rural demand, and rising competition. Tractor Supply focuses on farm, ranch, and rural lifestyle customers, a segment that has faced pressure from...

Moderna stock has delivered a strong 84.8% return year to date, yet its low valuation score and expensive market multiples raise questions about how much of the story is already in the price. The 84.8% gain year to date signals that investors have sharply repriced Moderna as expectations around its pipeline and future revenue have shifted. Progress in areas such as the mRNA-4200 cancer program and the pending FDA decision on the mRNA-1010 flu vaccine can support growth hopes. At the same...

McKesson Corporation recently approved a quarterly dividend of US$0.94 per share, payable on October 1, 2026, to shareholders of record as of the September 1, 2026 ex-dividend date, marking its tenth consecutive year of dividend increases. This 15% dividend raise, alongside ongoing portfolio streamlining and oncology expansion, underlines management’s focus on steady cash returns while reshaping the business mix. We’ll now examine how McKesson’s higher dividend and portfolio reshaping may...

Sharplink (SBET) is on investors’ radar after recent trading placed its market value around US$1.23b, with the stock closing at US$6.00 and showing mixed return patterns across different timeframes. See our latest analysis for Sharplink. Recent trading in Sharplink highlights a sharp contrast between shorter term share price momentum and longer term outcomes. The 30 day share price return is up 20.85%, while the year to date share price return is down 38.08% and the 1 year total shareholder...

Allison Transmission Holdings has delivered a 225.8% total return over the past five years, yet its current share price still screens as cheap against an intrinsic value estimate from a Discounted Cash Flow (DCF) model and supporting market multiples. Recent defense contract wins add fresh cash flow expectations into the mix, raising the question of whether the market is still underpricing that future stream. A 225.8% return over five years points to a stock that has already rewarded long...

Huntington Bancshares recently reported its second-quarter 2026 results, with net interest income rising to US$2,052 million and net income to US$727 million, while basic earnings per share from continuing operations edged down to US$0.34. The quarter also saw higher net charge-offs of US$119 million, completion of the Cadence systems conversion, and a US$59 million share buyback alongside an unchanged US$0.155 common dividend, highlighting both credit cost pressure and management’s focus on...

Renewed interest in Corteva (CTVA) is building as recent analyst commentary points to a strong record of topping earnings estimates and a positive Earnings ESP ahead of the upcoming quarterly report. See our latest analysis for Corteva. Corteva’s share price has moved to $88.78, with a 30 day share price return of 12.22% and a year to date share price return of 31.02%. The 5 year total shareholder return of 116.84% points to strong long term compounding and suggests momentum has been building...

BridgeBio Pharma recently announced that the FDA has accepted for filing its New Drug Application for encaleret to treat autosomal dominant hypocalcemia type 1, assigning a PDUFA target action date of May 8, 2027, and indicating no advisory committee meeting is currently planned. If approved, encaleret would be the first therapy specifically indicated for ADH1, targeting the underlying genetic cause and potentially obviating the need for chronic calcium and vitamin D supplementation in this...

Sinclair (SBGI) is back on investors’ radar after recent trading left the stock down 4% over the past month and 15% over the past 3 months, sharpening focus on its media-focused business model. See our latest analysis for Sinclair. At a share price of $13.37, Sinclair’s recent 7 day share price return of down 6.8% and year to date share price return of down 12.2% contrast with a 3 year total shareholder return of about 24%. This suggests recent momentum has faded even though longer term...

Bloom Energy stock has delivered a very large 3 year return, yet the valuation signals are split, with a discounted cash flow based intrinsic value estimate pointing to meaningful upside while market based multiples suggest the shares screen as expensive. That tension has grown more acute after recent news and contract wins around its fuel cell deployments for AI focused data centers. Bloom Energy has returned about 11.6x over the past 3 years, which puts more pressure on today’s buyers to...

Nike (NYSE:NKE) plans to shift all online sales in China to Nike-operated flagship stores on major platforms from 2027. The company intends to end online distribution through thousands of wholesale partners in the Greater China region. This reset focuses on tighter control of pricing, product selection, and brand presentation across Chinese ecommerce channels. Nike is a global sportswear company with a long-standing focus on direct-to-consumer channels, and China is one of its most...

Recent returns put Park National in focus Park National (PRK) is drawing investor attention after a run that includes a year to date total return of 19.8% and a past 3 months total return of 7.6%. These returns are prompting fresh questions about valuation and risk. See our latest analysis for Park National. Recent trading has cooled slightly, with the share price down 3.8% over the past week but still showing a 7.6% 90 day share price return and a 91.8% total shareholder return over five...

Caledonia Mining Corporation Plc recently reported second-quarter 2026 gold production of 17,360 ounces at its Blanket Mine in Zimbabwe, an 18% increase from the first quarter, alongside reaffirmed full-year production guidance of 72,000 to 76,500 ounces and steadily improving ore grades. At the same time, drilling at Blanket’s K-Pits target has revealed a new near-surface gold zone with oxide and deeper sulphide mineralisation, opening the possibility of a lower-cost heap leach operation...

After a sharp 21.9% gain over the past month, Thermo Fisher Scientific now sits in a more finely balanced spot on price. The Discounted Cash Flow (DCF) intrinsic value suggests the stock is roughly in line with fair value, while market based multiples lean more expensive. The 21.9% rise in the past month puts recent momentum front and center, which can leave less room for error if expectations later cool. Recent contract wins and product launches can support expectations for future cash...

Sprouts Farmers Market (SFM) has put its Innovation Set program in the spotlight by rolling out LivReal, a fruit flavored energy drink line, across stores nationwide, giving investors another data point on differentiated product trials. See our latest analysis for Sprouts Farmers Market. For context, Sprouts Farmers Market shares have eased in the short term, with the 30 day share price return down 13.04% and the year to date share price return down 8.87%. At the same time, the 5 year total...